Literature DB >> 32405313

Switching from Clonidine Immediate-Release to Guanfacine Extended-Release.

Dean Elbe1,2,3.   

Abstract

Entities:  

Year:  2020        PMID： 32405313      PMCID： PMC7213916     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN： 1719-8429


× No keyword cloud information.
  13 in total

1.  Use of sleep medication in children with ADHD.

Authors:  Daryl Efron; Kate Lycett; Emma Sciberras
Journal:  Sleep Med       Date:  2014-02-07       Impact factor: 3.492

2.  Clonidine in child and adolescent psychiatry.

Authors:  R D Hunt; L Capper; P O'Connell
Journal:  J Child Adolesc Psychopharmacol       Date:  1990       Impact factor: 2.576

3.  Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.

Authors:  Daniel F Connor; Robert L Findling; Scott H Kollins; Floyd Sallee; Frank A López; Andrew Lyne; Gerald Tremblay
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

4.  A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.

Authors:  Timothy E Wilens; Oscar Bukstein; Matthew Brams; Andrew J Cutler; Ann Childress; Thomas Rugino; Andrew Lyne; Kara Grannis; Sharon Youcha
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-11-25       Impact factor: 8.829

5.  A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman; Raun D Melmed; Anil Patel; Keith McBurnett; Jennifer Konow; Andrew Lyne; Noreen Scherer
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

6.  Clonidine treatment of hyperactive and impulsive children with autistic disorder.

Authors:  C A Jaselskis; E H Cook; K E Fletcher; B L Leventhal
Journal:  J Clin Psychopharmacol       Date:  1992-10       Impact factor: 3.153

7.  Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.

Authors:  Floyd R Sallee; James McGough; Tim Wigal; Jessica Donahue; Andrew Lyne; Joseph Biederman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-02       Impact factor: 8.829

8.  Focus on Guanfacine Extended-release: A Review of its Use in Child and Adolescent Psychiatry.

Authors:  Dean Elbe; Dorothy Reddy
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2014-02

9.  Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.

Authors:  Donna R Palumbo; Floyd R Sallee; William E Pelham; Oscar G Bukstein; W Burleson Daviss; Michael P McDERMOTT
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-02       Impact factor: 8.829

10.  Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration.

Authors:  Jeffrey H Newcorn; Mark A Stein; Ann C Childress; Sharon Youcha; Carla White; Gail Enright; Jonathan Rubin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-08-01       Impact factor: 8.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.